June 6, 2006 |
Allergan Inc., maker of the Botox wrinkle treatment, said the Food and Drug Administration approved its Juvederm dermal filler treatment targeting the folds alongside the nose and mouth. Separately, Allergan said it won a court ruling that would block Apotex Inc. from selling a generic version of a treatment for eye inflammation until 2009.
October 19, 1997 |
Allergan Inc. and Peptech Ltd. in England have terminated their agreement to develop a psoriasis treatment. Irvine-based Allergan, an eye-care products company, said Peptech has determined that further work is required to assess the optimal treatment regimen for the product, GMDP.
December 1, 1995
Allergan Inc. said Thursday that it has completed its previously announced acquisition of the Phoenix-based contact lens care business of British health-care products giant Pilkington Barnes Hind. Terms of the deal were not disclosed. Allergan, headquartered in Irvine, develops, makes and markets products for eye and skin care and neuromuscular disorders.
April 26, 2000
The Irvine research and development arm of eye-care company Allergan Inc. reported a net loss of $17.2 million, or $5.24 a share, for the first quarter, compared with a loss of $10.8 million, or $3.30 a share, for last year's first three months. Quarterly revenue fell to $980,000 from $2.15 million.